Nabriva Therapeutics PLC (NBRV)

1.43 -0.03 (-2.05%) USD  |  NASDAQ  |  Jun 05, 16:00
1.43 0.00 (0.00%) After-Hours: 16:22
More

Nabriva Therapeutics News

News

Headline
Wire
Time (ET)
NBRV, JNCE and ALIM among healthcare movers
SA Breaking News
03/27 10:47
7 Stocks to Sell as Banks Melt Down
Yahoo
03/20 18:20
Top Midday Decliners
MT Newswires
01/06 14:00
Sector Update: Health Care Stocks Posting Moderate Advance Friday Afternoon
MT Newswires
01/06 13:44
TANH, HKD and NXTP among mid-day movers
SA Breaking News
01/06 12:45
CVAC and ZYXI among healthcare movers
SA Breaking News
01/06 10:53
Sector Update: Health Care Stocks Gain Premarket Friday
MT Newswires
01/06 09:07
December Jobs Report Showing Easing Wage Pressures Lift US Equity Futures
MT Newswires
01/06 09:03
Nabriva Therapeutics Approves Wind-Down Plan, Will Terminate All Non-Essential Employees; Shares Fall Pre-Bell
MT Newswires
01/06 08:24
Top Premarket Decliners
MT Newswires
01/06 07:46
Nabriva Therapeutics rallies on positive topline results from Phase 1 trial of XENLETA
SA Breaking News
11/28 09:22
Nabriva Says Phase 1 Trial of Cystic Fibrosis Drug Candidate Shows Safety Profile in Line With Prior Studies in Healthy Subjects
MT Newswires
11/28 08:47
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS Reports Q3 Revenue $9.2M
MT Newswires
11/10 16:05
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS Posts Q3 Loss $-4.21
MT Newswires
11/10 16:04
Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update
Globe Newswire
11/10 16:01
Wall Street Set to Open Mixed as Jobless Report Better Than Expected
MT Newswires
09/15 09:13
Thinking about buying stock in Nabriva Therapeutics, Sonnet BioTherapeutics, Fast Radius, Volcon, or Velo3D?
PR Newswire
09/15 08:30
US Stock Futures Mixed Ahead of Jobless Claims
MT Newswires
09/15 08:19
Top Premarket Gainers
MT Newswires
09/15 08:01
Nabriva Therapeutics Announces Date of 1-for-25 Reverse Stock Split
Globe Newswire
09/15 07:01
Nabriva Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Globe Newswire
09/06 07:01
Nabriva Therapeutics Completes Patient Enrollment for Phase 1 Trial of Potential Cystic Fibrosis Drug
MT Newswires
08/11 11:26
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS Posts Q2 Loss $-0.18
MT Newswires
08/03 16:02
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS Reports Q2 Revenue $9.2M
MT Newswires
08/03 16:01
Nabriva Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
Globe Newswire
08/03 16:01
Nabriva Therapeutics to Report Second Quarter 2022 Financial Results and Recent Corporate Highlights on August 3, 2022
Globe Newswire
07/20 16:05
Sector Update: Health Care Stocks Extending Monday Slide
MT Newswires
07/18 16:04
Sector Update: Health Care Stocks Sinking in Monday Trading
MT Newswires
07/18 13:28
Wall Street Set for Gains as Earnings Season Picks Up Steam
MT Newswires
07/18 09:22
Top Premarket Gainers
MT Newswires
07/18 07:55
Nabriva stock soars 19% on distribution deal with Er-Kim for bacterial pneumonia drug Xenleta
SA Breaking News
07/18 07:27
Nabriva Therapeutics Signs Distribution Deal For Xenleta; Shares Gain Premarket
MT Newswires
07/18 07:22
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Posts Q1 Revenue $8M, vs. Street Est of $9.58M
MT Newswires
05/05 16:21
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Posts Q1 Loss $-0.20, vs. Street Est of $-0.19
MT Newswires
05/05 16:21
Nabriva Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
Globe Newswire
05/05 16:01
Nabriva Therapeutics Signs Extended Deal With Merck to Promote, Distribute Sivextro Through December 2026
MT Newswires
05/05 12:13
Nabriva Therapeutics to Report First Quarter 2022 Financial Results and Recent Corporate Highlights on May 5, 2022
Globe Newswire
05/02 16:05
Nabriva Therapeutics Enrolls First Patient in Cystic Fibrosis Study
MT Newswires
04/11 16:24
Nabriva Therapeutics Announces First Patient Enrolled in Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis
Globe Newswire
04/11 16:05
Northland Securities slashes Nabriva Therapeutics' price target
SA Breaking News
03/30 11:12
Nabriva 4Q results indicate slowdown in topline growth
SA Breaking News
03/29 17:01
Nabriva Therapeutics Q4 Loss Narrows, Revenue Rises
MT Newswires
03/29 16:40
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Reports Q4 Revenue $9.3M, vs. Street Est of $10.1M
MT Newswires
03/29 16:03
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Posts Q4 Loss $-0.24, vs. Street Est of $-0.19
MT Newswires
03/29 16:03
Nabriva Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
Globe Newswire
03/29 16:01
Earnings Reaction History: Nabriva Therapeutics plc, 55.6% Follow-Through Indicator, 11.6% Sensitive
MT Newswires
03/29 12:07
Nabriva Therapeutics Q4 2021 Earnings Preview
SA Breaking News
03/28 17:35
Nabriva Therapeutics to Report 2021 Financial Results and Recent Corporate Highlights on March 29, 2022
Globe Newswire
03/15 07:01
Nabriva Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
03/01 07:01
Nabriva Therapeutics Adjourns Extraordinary General Meeting of Shareholders on January 18, 2022
Globe Newswire
01/18 16:01
Nabriva Therapeutics Adjourns Extraordinary General Meeting of Shareholders
Globe Newswire
01/14 16:01
Nabriva Therapeutics to Adjourn Extraordinary General Meeting of Shareholders on December 22, 2021
Globe Newswire
12/22 09:20
Nabriva Says New Drug Application for Pneumonia Drug Candidate Lefamulin Accepted for Review by Chinese Regulator
MT Newswires
11/29 10:29
Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack
Globe Newswire
11/11 07:01
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Posts Q3 Revenue $8.9M, vs. Street Est of $8.9M
MT Newswires
11/09 16:10
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Posts Q3 Loss $-0.21, vs. Street Est of $-0.22
MT Newswires
11/09 16:10
Nabriva Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update
Globe Newswire
11/09 16:01
Nabriva Therapeutics to Present at the Jefferies London Healthcare Conference
Globe Newswire
11/05 07:01
Nabriva Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
11/01 07:01
Nabriva Therapeutics to Present Data at CHEST Annual Meeting 2021
Globe Newswire
10/15 16:05
Nabriva Publishes Data Demonstrating the Potent Anti-Inflammatory Properties of XENLETA® (lefamulin)
Globe Newswire
10/04 16:05
Nabriva Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
10/01 16:05
Nabriva Therapeutics Appoints Dr. Christine Guico-Pabia, M.D., as Chief Medical Officer
Globe Newswire
10/01 07:01
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021
PR Newswire
09/30 08:00
Nabriva Therapeutics to Present Data at IDWeek 2021
Globe Newswire
09/24 07:01
Nabriva and Vizient Enter into Agreement to Make XENLETA® (lefamulin) Available to Vizient’s Pharmacy Network Program
Globe Newswire
09/09 07:01
Thinking about buying stock in Nabriva Therapeutics, WiMi Hologram Cloud, Xos Inc, Altimmune, or Penn National Gaming?
PR Newswire
09/08 09:31
Nabriva Therapeutics' Xenleta Receives Approval in Taiwan to Treat Community-Acquired Pneumonia; Shares Rise Pre-Bell
MT Newswires
09/08 07:57
Lefamulin Receives Approval in Taiwan for Treatment of Community-Acquired Pneumonia
Globe Newswire
09/08 07:01
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
09/01 07:01
Thinking about buying stock in Westport Fuel Systems, Switch, Athersys, Nabriva Therapeutics, or Aurinia Pharmaceuticals?
PR Newswire
08/06 08:30
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Posts Q2 Revenue $8.2M, vs. Street Est of $5.99M
MT Newswires
08/05 16:12
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Posts Q2 Loss $-0.29, vs. Street Est of $-0.35
MT Newswires
08/05 16:12
Nabriva Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
Globe Newswire
08/05 16:01
Acurx Pharmaceuticals Joins the Antimicrobials Working Group
PR Newswire
08/05 08:00
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
08/03 16:27
Nabriva Therapeutics to Report Second Quarter 2021 Financial Results and Recent Corporate Highlights on August 5, 2021
Globe Newswire
07/22 07:01
Crestone Joins Antimicrobials Working Group
PR Newswire
06/08 11:18
Nabriva Negotiates Extension of Loan Repayments, Extends Cash Runway
MT Newswires
06/03 09:11
Nabriva Agrees to Extension of Principal Debt Repayments Under Existing Loan Agreement with Hercules Capital
Globe Newswire
06/03 07:01
Nabriva Announces Changes to its Board of Directors
Globe Newswire
06/02 18:02
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
06/01 07:01
Thinking about buying stock in SOS, GameStop, New Oriental Education, Asensus Surgical, or Nabriva Therapeutics?
PR Newswire
05/27 10:52
Midday Report: Wall Street Higher Midday, Led by Clothing Retailers
MT Newswires
05/26 12:46
Asensus Surgical, Nabriva Therapeutics leads healthcare gainers; Larimar Therapeutics, Travere Therapeutics among major losers
SA Breaking News
05/26 11:02
Wall Street Set for Narrow Gains; Retail, Tech Earnings in Focus
MT Newswires
05/26 09:12
Thinking about buying stock in AMC, Nabriva Therapeutics, GameStop, Pieris Pharmaceuticals, or Selecta Biosciences?
PR Newswire
05/26 08:32
Reddit names GameStop and AMC Entertainment among premarket gainers
SA Breaking News
05/26 08:21
Nabriva Therapeutics Phase 3 Trial of Antibiotic Medication for Bacterial Pneumonia Meets Primary Endpoint
MT Newswires
05/26 07:11
Nabriva antibiotic meets primary endpoint in phase 3 trial; shares soar 40%
SA Breaking News
05/25 17:47
NBRV, SELB, ANPC and TVTX among after-hours movers
SA Breaking News
05/25 17:42
Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)
Globe Newswire
05/25 17:00
Nabriva Therapeutics to Present at the Jefferies Virtual Healthcare Conference
Globe Newswire
05/21 07:01
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Reports Q1 Revenue $2.5M, vs. Street Est of $2.25M
MT Newswires
05/06 16:13
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Reports Q1 Loss $-0.53, vs. Street Est of $-0.69
MT Newswires
05/06 16:13
Nabriva Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
Globe Newswire
05/06 16:01
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
05/03 16:05
Nabriva Therapeutics to Report First Quarter 2021 Financial Results and Recent Corporate Highlights on May 6, 2021
Globe Newswire
04/29 16:05
Nabriva Therapeutics Begins Exclusive Distribution of Sivextro in US
MT Newswires
04/15 12:59
Nabriva commences exclusive distribution of SIVEXTRO in the U.S.
SA Breaking News
04/15 12:20
Nabriva Commences Exclusive Distribution of SIVEXTRO® (tedizolid phosphate) in the U.S.
Globe Newswire
04/15 12:12
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
04/02 16:01
Nabriva Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
Globe Newswire
04/01 08:00
Zhongchao, Immatics leads healthcare gainers; SunLink Health Systems, Rubius Therapeutics among major losers
SA Breaking News
03/17 11:02
Thinking about buying stock in FSD Pharma, Onconova Therapeutics, Nabriva Therapeutics, Zosano Pharma, or Savara?
PR Newswire
03/17 08:30
TNPX, ONTX, SVRA and NBRV among notable premarket gainers
SA Breaking News
03/17 08:24
Nabriva Publishes Clinical Data Analysis Highlighting Benefits of Outpatient Management of Community Acquired Bacterial Pneumonia (CABP) with Oral XENLETA® (lefamulin)
Globe Newswire
03/16 08:00
--Analyst Actions: Northland Securities Adjusts Nabriva Therapeutics' Price Target to $6 from $9, Keeps Outperform Rating
MT Newswires
03/12 10:44
Nabriva Therapeutics EPS misses by $0.33, beats on revenue
SA Breaking News
03/11 16:10
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Reports Q4 Loss $-1.11, vs. Street Est of $-0.94
MT Newswires
03/11 16:09
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Posts Q4 Revenue $2.5M, vs. Street Est of $0.604M
MT Newswires
03/11 16:09
Nabriva Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Updates
Globe Newswire
03/11 16:07
Nabriva Therapeutics to Report 2020 Financial Results and Recent Corporate Highlights on March 11, 2021
Globe Newswire
03/03 16:05
SOS, MNKD, CAN and OTRK among midday movers
SA Breaking News
03/01 12:44
Morphic, electroCore leads healthcare gainers; Athenex, Ontrak among major losers
SA Breaking News
03/01 11:02
Nabriva Therapeutics under pressure on $25.4M registered direct offering
SA Breaking News
03/01 08:31
Athenex, Xtant Medical among major healthcare premarket losers' pack
SA Breaking News
03/01 08:20
Nabriva Therapeutics Announces $25.4 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Globe Newswire
03/01 08:00
Nabriva Therapeutics Names Daniel Dolan CFO
MT Newswires
02/26 09:47
Nabriva names Daniel Dolan CFO
SA Breaking News
02/26 08:26
Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer
Globe Newswire
02/26 08:00
Study Demonstrates Macrolide-Resistance in S. pneumoniae in the United States Exceeds 25 Percent Threshold Set in Current Community-Acquired Bacterial Pneumonia (CABP) Treatment Guidelines
Globe Newswire
02/23 07:00
UTILITY Therapeutics Joins Antimicrobials Working Group
PR Newswire
02/17 10:04
Nabriva Therapeutics announces CFO retirement
SA Breaking News
02/01 16:51
Nabriva Therapeutics Chief Financial Officer Retires
MT Newswires
02/01 16:43
Nabriva Therapeutics Announces Retirement of its Chief Financial Officer
Globe Newswire
02/01 16:30
Nabriva Therapeutics to Participate in Upcoming Virtual Investor Conferences in January
Globe Newswire
01/05 16:01
Close Update: Major Stock Indexes Slump for Week After Mixed Performance Friday
MT Newswires
12/11 16:22
Midday Report: Wall Street Weaker Midday On Stimulus Woes
MT Newswires
12/11 13:02
XXII, VTVT, SLS and NBRV among midday movers
SA Breaking News
12/11 12:39
NantKwest and vTv Therapeutics among healthcare gainers; SELLAS Life Sciences and Nabriva Therapeutics among losers
SA Breaking News
12/11 10:57
Wall Street Sees Lower Open Amid Continued Uncertainty Over Stimulus Talks
MT Newswires
12/11 09:17
Lloyds Banking Group, Barclays leads premarket losers' pack
SA Breaking News
12/11 08:55
Nabriva Therapeutics Prices $15 Million Public Offering
MT Newswires
12/11 03:01
Nabriva Therapeutics prices $15M public offering
SA Breaking News
12/10 23:31
Nabriva Therapeutics Announces Pricing of $15 Million Public Offering
Globe Newswire
12/10 23:17
AHT, ARCT, NBRV and RMG among after-hours movers
SA Breaking News
12/10 17:48
Nabriva Therapeutics Slumps in Late Trading After Unveiling Offering of Ordinary Shares
MT Newswires
12/10 16:13
Nabriva Therapeutics Announces Proposed Public Offering
Globe Newswire
12/10 16:01
Nabriva Therapeutics shares gain as Sinovant expands Xenleta support in China
SA Breaking News
12/07 08:09
Nabriva Therapeutics, Sinovant Sciences Restructure License Agreement for Potential Pneumonia Drug Xenleta in China
MT Newswires
12/07 07:52
Nabriva Therapeutics and Sinovant Sciences Restructure License Agreement for XENLETA for Community-Acquired Bacterial Pneumonia in China
Globe Newswire
12/07 07:00
Thinking about buying stock in Nabriva Therapeutics, Workhorse Group, ReneSola, Riot Blockchain, or Oramed Pharmaceuticals?
PR Newswire
12/03 09:31
Wall Street Retreats Pre-Bell, Consolidating After Record-Setting Rally
MT Newswires
12/02 09:21
Nabriva Therapeutics Announces Date of 1-for-10 Reverse Stock Split
Globe Newswire
12/02 08:00
Nabriva Therapeutics to Participate in Upcoming Virtual Investor Conferences
Globe Newswire
11/12 07:01
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Reports Q3 Revenue $1.3M, vs. Street Est of $0.45M
MT Newswires
11/05 16:05
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US Posts Q3 EPS $-0.09, vs. Street Est of $-0.10
MT Newswires
11/05 16:05
Nabriva Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
Globe Newswire
11/05 16:01
Nabriva Therapeutics to Report Third Quarter 2020 Financial Results on November 5, 2020
Globe Newswire
11/02 16:01
Nabriva’s XENLETA Demonstrates High Efficacy in Patients of Advanced Age with Community-Acquired Bacterial Pneumonia (CABP)
Globe Newswire
10/13 07:00
Nabriva Therapeutics Receives New Technology Add-On Payment for Xenleta, Contepo
MT Newswires
09/10 11:12
Nabriva Therapeutics secures new technology add-on payment for Xenleta and Contepo
SA Breaking News
09/10 09:38
Nabriva Therapeutics Granted New Technology Add-On Payment for XENLETA® (lefamulin) and CONTEPO™ (fosfomycin) by Centers for Medicare & Medicaid Services
Globe Newswire
09/10 08:39
Nabriva Therapeutics Files for $150 Million Mixed Shelf - Stock Down 2% After-Hours
MT Newswires
09/01 17:33
Nabriva files for $150M mixed shelf
SA Breaking News
09/01 16:59
Nabriva Therapeutics to Participate in Upcoming Virtual Investor Conferences
Globe Newswire
08/31 07:00
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US INC Posts Q2 EPS $-0.14, vs. Street Est of $-0.16
MT Newswires
08/06 16:09
-- Earnings Flash (NBRV) NABRIVA THERAPEUTICS US INC Reports Q2 Revenue $487,000, vs. Street Est of $0.4M
MT Newswires
08/06 16:09
Nabriva Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates
Globe Newswire
08/06 16:01
Nabriva Therapeutics to Report Second Quarter 2020 Financial Results on August 6, 2020
Globe Newswire
08/03 07:00
Nabriva Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
Globe Newswire
07/30 16:01
Nabriva Secures Marketing Clearance in Europe for Community-Acquired Pneumonia Treatment Xenleta
MT Newswires
07/28 11:42
Nabriva's lefamulin OK'd in Europe for community-acquired pneumonia
SA Breaking News
07/28 10:14
NABRIVA Receives European Approval for XENLETA® (lefamulin) for Treatment of Community-Acquired Pneumonia (CAP)
Globe Newswire
07/28 10:02
Nabriva Therapeutics Says Lefamulin Shows Anti-Inflammatory Properties in Lung Neutrophilia
MT Newswires
07/23 15:20
Nabriva's lefamulin shows positive effect in lung inflammation model
SA Breaking News
07/23 07:48
Lefamulin Demonstrates Anti-Inflammatory Activity in Pre-Clinical Study
Globe Newswire
07/23 07:00
U.S. Small Cap Stocks Could Outperform The Market During The Recovery And Here Are Four Stocks You Need To Know About
Globe Newswire
07/22 07:00
After Hours Watch List Scorecard: NBRV, DELL, TCDA
MT Newswires
07/16 17:12
Nabriva Therapeutics' Canadian Partner Bags Regulatory Approval for Treatment of Community-Acquired Pneumonia - Shares Jump in Late Trade
MT Newswires
07/16 16:25
XENLETA® (lefamulin) Receives Health Canada Approval for Treatment of Community Acquired Pneumonia
Globe Newswire
07/16 16:04
Sector Update: Late Bounce for Biotech Shares Helps Limit Decline for Health Care Stocks
MT Newswires
07/16 15:58
Sector Update: Health Care Stocks Weaken in Thursday Selloff
MT Newswires
07/16 13:47
Thinking about buying stock in Plug Power, Nabriva Therapeutics, electroCore Inc, Spirit Airlines, or TOP Ships?
PR Newswire
07/16 09:31
Wall Street Set for Lower Open; Jobless Claims Hit 1.3 Million
MT Newswires
07/16 09:03
MT Newswires After Hours Watch List: NBRV, DELL, TCDA
MT Newswires
07/15 17:53
Merck Picks Nabriva Therapeutics to Sell Sivextro for Skin Infections in the US - NBRV Jumps 20%
MT Newswires
07/15 16:13
Nabriva Therapeutics Enters into Exclusive Agreement to Promote and Distribute SIVEXTRO® (tedizolid phosphate) in the U.S.
Globe Newswire
07/15 16:01
Nabriva's lefamulin OK'd in Canada for community-acquired pneumonia
SA Breaking News
07/15 09:46
Analyst Actions: Northland Securities Cuts Nabriva Therapeutics AG's Price Target to $1.50 From $2.50, Keeps at Outperform
MT Newswires
06/22 12:44
Wall Street Futures Rise in Volatile Trading, Resurgence of Virus Cases Spooks Sentiment
MT Newswires
06/22 09:09
Nabriva Therapeutics to Request Meeting With FDA Over Resubmission of Contenpo Application
MT Newswires
06/22 03:39
Nabriva strikes out again on FDA nod for fosfomycin
SA Breaking News
06/20 11:10
Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for CONTEPO™ (fosfomycin) for injection
Globe Newswire
06/19 20:52
MYOV, NBRV, RWLK and WWR among midday movers
SA Breaking News
06/01 12:43
CTI BioPharma among healthcare gainers; Nabriva Therapeutics among the losers
SA Breaking News
06/01 11:03
EVH, PFE among premarket losers
SA Breaking News
06/01 09:21
Wall Street Sees Narrowly Mixed Open as Civil Unrest Rages Across US
MT Newswires
06/01 09:05
Nabriva to Raise $38 Million from Direct Offering of Stock, Warrants
MT Newswires
06/01 06:06
Nabriva secures private $38M capital raise
SA Breaking News
05/30 11:43
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Globe Newswire
05/29 19:31
Nabriva Therapeutics Receives Positive EU Opinion for XENLETA to Treat Community-Acquired Pneumonia; Shares Surge 36%
MT Newswires
05/29 13:04
Nabriva Therapeutics Receives Positive EU CHMP Opinion for XENLETA™ (lefamulin) for the Treatment of Community-Acquired Pneumonia (CAP)
Globe Newswire
05/29 08:00
European advisory group backs Nabriva's lefamulin
SA Breaking News
05/29 07:50
Nabriva Therapeutics to Present at the Jefferies Virtual Healthcare Conference
Globe Newswire
05/27 16:01
National Burden of Macrolide-Resistant Streptococcus Pneumoniae in the United States From Blood and Respiratory Tract Cultures Approaches 40 Percent
Globe Newswire
05/18 08:00
Nabriva Therapeutics EPS beats by $0.02, beats on revenue
SA Breaking News
05/11 16:04
Nabriva Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Updates
Globe Newswire
05/11 16:01
Nabriva Therapeutics to Present at the BofA Securities 2020 Virtual Health Care Conference
Globe Newswire
05/11 07:00
Nabriva Therapeutics to Report First Quarter 2020 Financial Results on May 11, 2020
Globe Newswire
05/08 07:00
Nabriva up 11% premarket on publication of positive lefamulin data
SA Breaking News
05/05 08:44
XENLETA® (Lefamulin) Treatment Results in a Rapid Time-to-Clinical Response in Hospitalized Patients with Community-Acquired Bacterial Pneumonia (CABP)
Globe Newswire
05/05 07:00
--Analyst Actions: HC Wainwright Downgrades Nabriva Therapeutics to Neutral From Buy
MT Newswires
04/09 08:26
Evercore bearish on medical device makers in premarket analyst action
SA Breaking News
04/09 07:32
Centers for Medicare & Medicaid Services Issues Product-Specific J-Code for XENLETA
Globe Newswire
04/09 07:00
Nabriva Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
Globe Newswire
04/08 07:00
Berenberg sees 93% upside in Alnylam in premarket analyst action
SA Breaking News
03/19 07:34
--Analyst Actions: Wedbush Downgrades Nabriva Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $6
MT Newswires
03/19 06:51
--Analyst Actions: Morgan Stanley Downgrades Nabriva Therapeutics to Equal-Weight From Overweight, Cuts PT to $2 From $7
MT Newswires
03/17 12:10
BMO likes Blueprint Medicines in premarket analyst action
SA Breaking News
03/17 07:31
SOHO, TLRY, CPLG and BLCM among midday movers
SA Breaking News
03/13 12:44
Healthcare - Top 5 Gainers / Losers
SA Breaking News
03/13 11:04
--Analyst Actions: Needham Cuts Price Target on Nabriva Therapeutics to $5 From $10, Maintains Buy
MT Newswires
03/13 11:00
Healthcare stocks dominate premarket losers
SA Breaking News
03/13 09:09
MT Newswires After-Hours News Movers
MT Newswires
03/12 17:57
Nabriva Therapeutics AG Q4 Sales Miss Estimates But Loss Per Share Narrower
MT Newswires
03/12 16:05
Nabriva Therapeutics EPS beats by $0.05, misses on revenue
SA Breaking News
03/12 16:03
Nabriva Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results and Recent Corporate Highlights
Globe Newswire
03/12 16:01
Nabriva Therapeutics to Report 2019 Financial Results and Recent Corporate Highlights on March 12, 2020
Globe Newswire
03/10 16:01
Nabriva Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
03/02 16:01
Vaccinex joins coronavirus-stoked rally, up 39%
SA Breaking News
01/24 15:59
Respiratory virus in China less virulent than 2003 SARS
SA Breaking News
01/23 06:59
Coronavirus vaccine prospects boost Moderna premarket, up 6%
SA Breaking News
01/22 07:52
Infectious disease drug developers rally on coronavirus outbreak in China
SA Breaking News
01/21 13:36
Wall Street Sees Upbeat Session on Signs of Easing US-Iran Tensions
MT Newswires
01/09 09:17
SNCA, NBRV among premarket gainers
SA Breaking News
01/09 09:15
MT Newswires After-Hours News Movers
MT Newswires
01/08 17:49
Nabriva Says US FDA Receives NDA Resubmission for Contepo for Treatment of Complicated Urinary Tract Infections
MT Newswires
01/08 16:12
FDA accepts Nabriva's refiled Contepo application; shares up 8% after hours
SA Breaking News
01/08 16:10
Nabriva Therapeutics Receives FDA Acknowledgement of New Drug Application Resubmission for Intravenous CONTEPO™ (fosfomycin) for Injection
Globe Newswire
01/08 16:01
Analyst Actions: Wedbush Lowers Price Target for Nabriva Therapeutics AG to $6 From $7, Maintains Outperform Rating
MT Newswires
12/27 16:02
Close Update: Major Market Indexes Climb to Record Closes
MT Newswires
12/20 16:33
Midday Update: Stock Indexes Rising Friday After Trump Tweets About Talk With China's Xi
MT Newswires
12/20 12:56
RAD, CAMP, ABEO and MRNS in midday movers
SA Breaking News
12/20 12:38
Marinus Pharmaceuticals leads healthcare gainers; Abeona Therapeutics among losers
SA Breaking News
12/20 11:00
Nabriva down 20% on equity offering
SA Breaking News
12/20 10:10
Nabriva Therapeutics Launches $20 Million Registered Direct Offering
MT Newswires
12/20 09:22
Wall Street Set for Positive Open as US Economy Expands by 2.1% in Q3
MT Newswires
12/20 09:18
X, MITO among premarket losers
SA Breaking News
12/20 09:12
Nabriva Therapeutics Announces $20 Million Registered Direct Offering
Globe Newswire
12/20 08:37
Nabriva Resubmits New Drug Application for Urinary Tract Infection Injection
MT Newswires
12/20 07:03
Nabriva refiles U.S. Contepo application; shares up 10% premarket
SA Breaking News
12/20 06:44
Nabriva Therapeutics Resubmits New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection
Globe Newswire
12/20 06:00
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
12/02 16:01
Nabriva Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
Globe Newswire
11/21 16:01
Nabriva Therapeutics Commends the CDC on the 2019 Antibiotic Resistance Threats Report, Highlighting the Need for New Antibiotics Aligned with Antibiotic Stewardship
Globe Newswire
11/18 07:00
YY, CLVS among premarket gainers
SA Breaking News
11/13 09:10
MT Newswires After-Hours News Movers
MT Newswires
11/12 17:59
Nabriva Therapeutics Posts Narrower-Than-Estimated Q3 Loss; Revenue Tops
MT Newswires
11/12 16:39